Evogene develops novel products for life science markets through the use of a unique computational predictive biology platform. Currently, the Company focuses on three key target markets: Seeds – addressing essential seed traits such as: yield, environmental stresses and resistance to insects and diseases; Ag-Chemicals – developing novel herbicides and insecticides; and Ag-Biologicals – developing a broad range of bio-stimulants & bio-pesticides

Evogene’s business model is composed of independent or collaborative R&D with advanced development and commercialization conducted by our partners. Evogene currently has strategic collaborations and licensing agreements with world-leading agricultural companies, such as: BASF, Corteva, ICL, Monsanto and more. Evogene has two subsidiaries: Evofuel – focused on the development and commercialization of castor seeds; snf Biomica – focused on the discovery and development of human microbiome-based therapeutics.

The company recently released this illuminating overview of the technology and company promise and progress.

Novel products for life science markets: The Digest’s 2018 Multi-Slide Guide to Evogene